Egyptian Drug Authority · Egypt
DEA-EG-2022-0025
Tier 1 · Regulator-publishedUnclassifiedPublic warningStatus · active
- Issuing authority
- Egyptian Drug Authority (EDA)
- Authority reference
- Periodic report no.(25) For 2022
- Date issued
- 20 Oct 2022
- Recorded by us
- 2026-09-06 19:45:29 UTC
- Product
- Vigamox 5mg/ml Eye Drops Solution
- INN / active substance
- Not stated by the issuing authority
- Dosage form
- Not stated by the issuing authority
- Strength
- Not stated by the issuing authority
- Manufacturer
- Not stated by the issuing authority
- Manufacturer country
- Not stated by the issuing authority
- MAH or importer
- Not stated by the issuing authority
- Batch numbers
- 22B24AA
- Expiry dates
- Not published with the notice
- Action type
- Public warning
- Classification
- Not stated by the issuing authority
- Indicative severity
- Not assessed by Drug Eye Africa
- Defect category
- Not stated by the issuing authority
- Product type
- Not stated by the issuing authority
- ATC code
- Not stated by the issuing authority
- Affected markets
- Egypt — no market beyond the issuing country was named on the notice
- Cross-border event
- Not linked to a cross-border event
- Notice text
- @egyptiandrugauthority
www.edaegypt.gov.eg
15301
٠٢ أكتوبر٢٢٠٢
يتم ضبط وتحريز العبوات المقلدة من المستحضر التالي:
Vigamox 5mg/ml Eye Drops Solution
21J20BA- 22B24AAتشغيلة رقم
حيث يمكن التفرقة ظاهرياً بين العبوات الأصلية والعبوات غير الأصلية
للمستحضر المذكور -وذلك بناءً على ماورد إلينا من الشركة صاحبة
المستحضر- كالآتي:
منشور
غش تجاري
@egyptiandrugauthority
www.edaegypt.gov.eg
15301
Vigamox 5mg/ml
Eye Drops Solution
21J20BA- 22B24AAتشغيلة رقمOriginal language: ar
- Notice text in English
- Egyptian Drug Authority trade-counterfeiting circular. Counterfeit packs of the following product are to be impounded and seized: Vigamox 5mg/ml Eye Drops Solution, batch numbers 21J20BA and 22B24AA. Genuine and non-genuine packs of the product can be told apart by sight, on the basis of what the company that owns the product has reported to the Authority. Dated 20 October 2022.Machine translation, produced by Drug Eye Africa and not checked by the issuing authority. The authority stated only the text above it.
- Status
- Active
- Superseded by
- Not superseded. This is the current version.
- Version
- 1
Where this record came from, and what is held to show it.
- Copy of the source
- Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.Ask us for it and check it against the fingerprint below.
- Fingerprint
- 7f057e064f17ee5a439c6c670e3f54c016dbf5d5ec6d49d6f19a455d2c0cc5c8SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
- Copy taken
- 2026-09-06 20:36:12 UTC
Cite this record
Drug Eye Africa (2022). DEA-EG-2022-0025: Vigamox 5mg/ml Eye Drops Solution — Public warning, Egyptian Drug Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/eg/2022/dea-eg-2022-0025Version history
—No version history recorded for this record.
—Corrections appear here and in the site-wide log. Records are superseded, never deleted.
Verification
Tier 1 — Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.
Indexing
This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.